 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Ocala, FL.

Current Price	$0.4784
Prev Close	$0.4784
Open	$0.475
Dividend Yield	0.00%
50-Day Moving Average	$0.463
Beta	0.69
Avg. Volume	110,900.89
PE Ratio	-1.19

52-Week High	$1.05
52-Week Low	$0.291
Market Capitalization	$23.16M
EPS	-$0.4007
Price to Book	0.68
Revenue Per Employee	$6,500.00
Enterprise Value/EBITDA	0.41

AIM AIM ImmunoTech Inc

About

Feed

Fundamentals

News